Cargando…

Clinical features and risk factors associated with morbidity and mortality among patients with COVID-19 in northern Ethiopia

OBJECTIVE: To describe the clinical features and assess the determinants of severity and in-hospital mortality of patients with coronavirus disease 2019 (COVID-19) from a unique setting in Ethiopia. METHODS: Consecutive patients admitted to a COVID-19 isolation and treatment centre were included in...

Descripción completa

Detalles Bibliográficos
Autores principales: Abraha, Hiluf Ebuy, Gessesse, Zekarias, Gebrecherkos, Teklay, Kebede, Yazezew, Weldegiargis, Aregawi Weldegebreal, Tequare, Mengistu Hagazi, Welderufael, Abadi Luel, Zenebe, Dawit, Gebremariam, Asqual Gebreslassie, Dawit, Tsega Cherkos, Gebremedhin, Daniel Woldu, de Wit, Tobias Rinke, Wolday, Dawit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7962557/
https://www.ncbi.nlm.nih.gov/pubmed/33741488
http://dx.doi.org/10.1016/j.ijid.2021.03.037
Descripción
Sumario:OBJECTIVE: To describe the clinical features and assess the determinants of severity and in-hospital mortality of patients with coronavirus disease 2019 (COVID-19) from a unique setting in Ethiopia. METHODS: Consecutive patients admitted to a COVID-19 isolation and treatment centre were included in this study. The overall clinical spectrum of COVID-19, and factors associated with risk of severe COVID-19 and in-hospital mortality were analysed. RESULTS: Of 2617 quarantined patients, three-quarters (n = 1935, 74%) were asymptomatic and only 114 (4.4%) presented with severe COVID-19. Common characteristics among the 682 symptomatic patients were cough (n = 354, 50.6%), myalgia (n = 212, 31.1%), headache (n = 196, 28.7%), fever (n = 161, 23.6%), dyspnoea (n = 111, 16.3%), anosmia and/or dysgeusia (n = 90, 13.2%), sore throat (n = 87, 12.8%) and chest pain (n = 77, 11.3%). Factors associated with severe COVID-19 were older age [adjusted relative risk (aRR) 1.78, 95% confidence interval (CI) 1.61–1.97; P < 0.0001], diabetes (aRR 2.00, 95% CI 1.20–3.32; P = 0.007), cardiovascular disease (aRR 2.53, 95% CI 1.53–4.17; P < 0.0001), malignancy (aRR 4.57, 95% CI 1.62–12.87; P = 0.004), surgery/trauma (aRR 23.98, 95% CI 10.35–55.57; P < 0.0001) and human immunodeficiency virus infection (aRR 4.24, 95% CI 1.55–11.61; P = 005). Factors associated with risk of in-hospital mortality included older age (aRR 2.37, 95% CI 1.90–2.95; P < 0.001), malignancy (aRR 6.73, 95% CI 1.50–30.16; P = 0.013) and surgery/trauma (aRR 59.52, 95% CI 12.90–274.68; P < 0.0001). CONCLUSIONS: A significant proportion of cases of COVID-19 were asymptomatic, and key comorbid conditions increased the risk of severe COVID-19 and in-hospital mortality. These findings could help in the design of appropriate management strategies for patients.